Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Operating Margin (2020 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Operating Margin for 6 consecutive years, with 1.52% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Margin rose 7307.0% year-over-year to 1.52%, compared with a TTM value of 12.02% through Sep 2025, down 1543.0%, and an annual FY2024 reading of 5.4%, up 6550.0% over the prior year.
  • Operating Margin was 1.52% for Q3 2025 at Fennec Pharmaceuticals, up from 28.31% in the prior quarter.
  • Across five years, Operating Margin topped out at 43555.56% in Q2 2021 and bottomed at 8182.35% in Q3 2021.
  • Average Operating Margin over 5 years is 2768.58%, with a median of 15.61% recorded in 2023.
  • The sharpest move saw Operating Margin tumbled -642804bps in 2023, then surged 36841bps in 2024.
  • Year by year, Operating Margin stood at 8182.35% in 2021, then skyrocketed by 108bps to 671.23% in 2022, then crashed by -103bps to 18.67% in 2023, then soared by 37bps to 11.79% in 2024, then surged by 87bps to 1.52% in 2025.
  • Business Quant data shows Operating Margin for FENC at 1.52% in Q3 2025, 28.31% in Q2 2025, and 9.23% in Q1 2025.